HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

South East Asia Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


South East Asia Radiopharmaceutical Synthesizer Market Insights

  • As per Reed Intelligence insights, the South East Asia Radiopharmaceutical Synthesizer Market stood at USD 93.66 Million in 2024 and is anticipated to grow to USD 138.35 Million by 2033.
  • The South East Asia market is expected to advance at a CAGR of 4.44% from 2026 through 2033.
  • In 2024, PET accounted for the highest share of the Modality market size.
  • During the forecast period, Others is set to register the highest growth, making it the most lucrative Modality segment.

Other Key Findings


  • South East Asia accounted for 2.99% of the global Radiopharmaceutical Synthesizer Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Radiopharmaceutical Synthesizer Market size by 2033.
  • Singapore will be the fastest-growing market in Asia Pacific, projected to achieve USD 27.98 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 93.66 Million
Market Size In 2033 USD 138.35 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.44% (2025-2033)
Segmnetation Covered
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports